BAYER AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.21 EUR | -0.37% |
|
+4.33% | -19.09% |
| 03:02pm | Bayer: licensing agreement for biological insecticide | CF |
| 11:33am | BAYER AG : Deutsche Bank reiterates its Neutral rating | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
2024-04-26
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
27.32
EUR
Average target price
37.05
EUR
Spread / Average Target
+35.63%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -19.09% | 28.56B | |
| +26.43% | 659B | |
| +26.46% | 557B | |
| -5.24% | 359B | |
| +16.84% | 322B | |
| +9.07% | 297B | |
| +5.87% | 215B | |
| +4.91% | 210B | |
| -6.09% | 200B | |
| -8.48% | 149B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Bayer Gets Japanese Regulatory Nod For Eye Drug in Preterm Infants
